期刊文献+

沙利度胺对胶原诱导型关节炎大鼠关节炎症的抑制作用及其机制探讨 被引量:1

Mechanisms underlying the anti-arthritic effects of Thalidomide in collagen Ⅱ-induced arthritis rat models
下载PDF
导出
摘要 目的研究沙利度胺对胶原诱导型关节炎大鼠的关节炎症及血浆血管内皮生长因子(VEGF)表达的影响。方法采用胶原诱导型关节炎(CIA)大鼠为动物模型,经给予沙利度胺治疗,测定不同时间点大鼠的足爪厚度、血浆VEGF浓度,进行踝关节病理评分和放射学检查,并与正常对照组、单纯造模组、甲氨蝶呤治疗组相比较。结果沙利度胺可以有效减轻CIA大鼠足爪肿胀程度,降低血浆VEGF浓度,疗效与甲氨蝶呤相似。结论沙利度胺可以通过影响VEGF的表达,抑制滑膜炎症及周围组织破坏,有效减轻CIA大鼠关节的炎症程度。 Objective To determine the effects of Thalidomide on arthropathy and in collagen Ⅱ -induced arthritis (CIA) rat models. Methods A group of CIA rat models were treated with thalidomide. Of this group, the thickness of rat claw and plasma VEGF concentration, pathological score and radiography of ankle joint were evaluated at different time spots and compared with those of normal group, untreated CIA group and MTX-treated group. Results Thalidomide was showed to result in relieved swelling of ankle joint, reduced plasma concentration of VEGF, lowered pathological score, and delayed progression of bony destruction, with therapeutic effects comparable to MTX. Conclusion Thalidomide may effectively ameliorate the arthropathy in CIA rat models by modulated VEGF expression, suppressed synovitis and bony destruction.
出处 《中国药物与临床》 CAS 2008年第2期106-109,共4页 Chinese Remedies & Clinics
关键词 关节炎 实验性 血管内皮生长因子A 沙利度胺 Arthritis, experimental Vascular endothelial growth factor A Thalidomide
  • 相关文献

参考文献13

  • 1Joosten Leo AB, Helsen Monique MA, Saxne T, et al. IL-1a blockade prevents cartilage and bone destruction in murine type Ⅱ collagen-induced arthritis, whereas TNF-α Blockade only ameliorates joint inflammation, hnmunology,1999,163: 5049- 5055. 被引量:1
  • 2Romas E. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol, 2002,161(4):1419-1427. 被引量:1
  • 3Takayanagi H, Juji T, Miyazaki T, et al. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Invest, 1999, 104 (2):137- 146. 被引量:1
  • 4Seidel MF, Rolf K, Hans V, et al. ICAM-1/LFA-1 expression in acute osteodestructive joint lesions in collagen-induced Arthritis in rats. Histochem Cytochem, 1997,45:1247-1254. 被引量:1
  • 5Luo F, Wariaro D, Lundberg G, et al. Vascular growth factor expression in a rat model of severe limb ischemia. J Surg Res, 2002,108 (2):258-267. 被引量:1
  • 6邓志宏.血管内皮生长因子[J].国外医学(生理病理科学与临床分册),1997,17(3):234-237. 被引量:17
  • 7Davis C. Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum, 2004,34: 668-677. 被引量:1
  • 8Gelati M,Corsini E,Frigerio S, et al. Effects of thalidomide on parameters involved in angiogenesis: an in vitro study. Neuro-Oncology, 2003,64 (3): 193. 被引量:1
  • 9Michael EF, Gordon RM, William DF. Thalidomide. Lancet, 2004,363(9423):1802-1811. 被引量:1
  • 10Hauschild A, Kroeger H, Mitchison NA, et al. Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift. Clin Exp Immunol, 1997,108 (3):428-431. 被引量:1

共引文献16

同被引文献12

  • 1范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 2Ross R. Atherosclerosis--an inflammatory disease [ J ]. N Engl J Med, 1999, 340 (2) : 115-126. 被引量:1
  • 3Libby P, Ridker PM, Maseri A. Inflammation and atherosclemsis [ J ]. Circulation, 2002, 105 (9) : 1 135-143. 被引量:1
  • 4Robbie L, Libby P. Inflammation and atherothrombosis [J]. Ann NY Acad Sci, 2001,947: 167-179. 被引量:1
  • 5Joki T, Vaananen I, Th~didomide and embryopathies. Report of 2 cases [J]. Duodecim, 1962, 78: 822-827. 被引量:1
  • 6Smtthes RW. 'ltlalidomide and malformations in Liverpool [J]. Lancet, 1962, 1(7 242): 1 270-273. 被引量:1
  • 7Ye Q, Chen B, Tong Z, et al. Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrcphages in interstitial lung disease [J]. Eur Respir J, 2006, 28 (4) :824-831. 被引量:1
  • 8Dmoszynska A, Podhorecka M, Manko J, et ah The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma [J]. Neoplasma, 2005, 52 (2) : 175-181. 被引量:1
  • 9Paravar T, Lee DJ. Thalidomide: mechanisms of action [ J ]. Int Rev Immunol, 2008, 27 (3) : 111-135. 被引量:1
  • 10Yasui K, Kobayashi N, Yamazaki T, et al. Thalidomide as an immunotherapeutic agent : the effects on neutrophil-mediated inflammation [ J]. CurrPharm Des, 2005, 11 (3) : 395-401. 被引量:1

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部